AN INDICATION FOR RECOVERY FROM ROTATOR CUFF TENDINOPATHY (RCT)
Here you will find detailed information why TendoVis™ promotes the recovery of Rotator Cuff Tendinopathy (RCT). Take some time to browse the sections below.
TendoVis™ has received approval for Rotator Cuff Tendinopathy. TendoVis™ is administered by a trained medical professional using antero-lateral approach to introduce the BIOCOMPATIBLE Hyaluronic Acid (STABHA™) along the injured ligament or tendon for a speedier recovery.
The main content of TendoVis™ is STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid). TendoVis™ is a registered product. Both TendoVis™ and the manufacturing process for STABHA™ are patented.
A large clinical study conducted over a period of 6 months demonstrated the following results:
Patients with Rotator Cuff Tendinopathy had lesser pain when resting and using the shoulder up to 6 months after using TendoVis™.
Patients with Rotator Cuff Tendinopathy had an increase in joint function up to 6 months after using TendoVis™.
Hyaluronic acid had an ancillary effect of reducing pain and limiting inflammation.
TendoVis™ containing STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid) will help reduce pain and limit inflammation in RCT.
It is recommended that patients suffering from Rotator Cuff Tendinopathy receive 2 injections of TendoVis™, with the 2nd injection administrated two weeks after the 1st administration.
There is no set time frame for using TendoVis™ if you are suffering from Rotator Cuff Tendinopathy.
TendoVis™ introduces STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid) to the site to promote recovery. It also aids by lubricating the injury site facilitating the realignment of the injured tissue fibres to its ideal position for increased tensile strength for a speedier and better recovery.